Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains. 1998

K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

The synthesis and antibacterial activity of 1beta-methylcarbapenems with quaternary ammonium groups at the C-2 position have been studied. Two types of new carbapenem derivatives have been synthesized. These 1beta-methylcarbapenems, one type having a (2S,4S)-2-[1,1-dimethyl-2-(1-piperazinyl)carbonyl]pyrrolidinio-4-+ ++ylthio group and the other type having a (2S,4S)-2-(4-carbamoylmethyl-4-methylhomopiperazinio-1-yl carbonyl)pyrrolidin-4-ylthio group, show potent and well balanced antibacterial activity as well as high stability against dehydropeptidase-I. The in vivo potency of these two carbapenems was compared with that of meropenem. The structure-activity relationships leading to these carbapenems are also described.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015780 Carbapenems A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain. Antibiotics, Carbapenem,Carbapenem,Carbapenem Antibiotics
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
June 2000, Bioorganic & medicinal chemistry letters,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
July 1950, The Journal of pharmacology and experimental therapeutics,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
January 2009, Chemistry (Weinheim an der Bergstrasse, Germany),
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
December 2003, Bioorganic & medicinal chemistry letters,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
May 1994, The Journal of antibiotics,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
February 2003, Bioorganic & medicinal chemistry letters,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
January 2010, Journal of medicinal chemistry,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
February 1992, Arzneimittel-Forschung,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
January 2000, Bioorganic & medicinal chemistry letters,
K Ishikawa, and K Kojima, and M Miyauchi, and R Endo, and H Yasuda, and I Kawamoto
February 1996, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!